Home
Market
IPO
Screener
Bundles
Super Investors
Sector
Discover
TickerPlus
Account
Swiss Parenterals
Standalone
Peers
P&L
Balance Sheet
Cash Flows
Corp. Action
News
Ticker
>
Company
>
Swiss Parenterals share price
Swiss Parenterals Ltd.
SECTOR:
Pharmaceuticals & Drugs
2619
1
0
The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.
Peer Comparison
View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.
Ratios
Sales Growth
1 Year
30.44%
3 Year
82.04%
5 Year
44.01%
Profit Growth
1 Year
18.32%
3 Year
198.62%
5 Year
85.92%
ROE%
1 Year
30.7%
3 Year
31.87%
5 Year
22.23%
ROCE %
1 Year
42.82%
3 Year
42.67%
5 Year
30.67%
Debt/Equity
0.1091
Price to Cash Flow
0
Interest Cover Ratio
87.847
CFO/PAT
(5 Yr. Avg.)
0.974037116384545
Strengths
The company has shown a good revenue growth of
82.0371909276696
% for the Past 3 years.
Company has been maintaining healthy ROE of
31.8709960410318
% over the past 3 years.
Company has been maintaining healthy ROCE of
42.6712682367753
% over the past 3 years.
Company has a healthy Interest coverage ratio of
87.847
.
The Company has been maintaining an effective average operating margins of
23.1578842471423
% in the last 5 years.
The company has an efficient Cash Conversion Cycle of
20.6144
days.
Limitations
Looks like the company does not have any serious limitations.
Profit & Loss
(All Figures in Cr. Adjusted EPS in Rs.)
PARTICULARS
Mar 2015
Mar 2016
Mar 2017
Mar 2023
Mar 2024
Net Sales
48.35
48.29
56.69
223.32
291.29
Total Expenditure
41.59
39.64
42.82
145.82
211.31
Operating Profit
6.76
8.65
13.87
77.5
79.98
Other Income
0.33
0.68
0.71
11.87
27.54
Interest
2.07
1.69
1.19
0.98
1.18
Depreciation
3.92
3.58
3.11
7.79
3.59
Exceptional Items
0
0
0
0
0
Profit Before Tax
1.11
4.06
10.28
80.59
102.74
Tax
0.39
1.43
3.81
21.5
32.82
Net Profit
0.72
2.63
6.46
59.09
69.92
Adjusted EPS (Rs.)
1.3
0
8.77
80.17
125.25
Balance Sheet
(All Figures are in Crores.)
Particulars
Mar 2015
Mar 2016
Mar 2017
Mar 2023
Mar 2024
Equity and Liabilities
Share Capital
1.24
1.64
7.37
7.37
5.58
Total Reserves
17.21
25.43
26.21
264.71
177.82
Borrowings
11.29
5.89
6.15
0
0
Other N/C liabilities
0.12
-0.17
-0.38
4.1
0.73
Current liabilities
29.13
17.33
28.21
63.31
121.17
Total Liabilities
58.98
50.12
67.57
339.49
305.3
Assets
Net Block
23.86
20.89
18.92
46.78
59.11
Capital WIP
0.18
0.32
4.21
1.81
0.21
Intangible WIP
0
0
0
0
0
Investments
0
0
0
15.38
5
Loans & Advances
0.48
0.5
3.08
25.67
32.43
Other N/C Assets
0
0
0.47
76.89
0.18
Current Assets
34.46
28.42
40.89
172.96
208.38
Total Assets
58.98
50.12
67.57
339.49
305.3
* Other Non-current Liabilities include Net deferred Liabilities
Cash Flows
(All Figures are in Crores.)
PARTICULARS
Mar 2023
Mar 2024
Profit from operations
80.59
102.74
Adjustment
1.86
-19.02
Changes in Assets & Liabilities
-43.87
54.65
Tax Paid
-24.11
-31.27
Operating Cash Flow
14.48
107.1
Investing Cash Flow
-9.19
32.12
Financing Cash Flow
10.07
-148.86
Net Cash Flow
15.37
-9.64
Corporate Actions
Dividend
Bonus
Rights
Split
Company News
No Latest News available for this company.
Report us
Last Updated on:
Brief about Swiss Parenterals
x
Ratio Delete Confirmation
×
Are you sure you want to DELETE
from your ratio list? This will also hide it from all other companies that you analyze.
X